U.S. Varicose Vein Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Sclerotherapy, Surgical Ligation & Stripping), And Segment Forecasts, 2019 - 2026

Published: Nov, 2019 | Pages: 75 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The U.S. varicose vein treatment devices market size is expected to reach USD 706.3 million by 2026, registering a CAGR of 5.5% over the forecast period, according to a new report published by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as obesity, pregnancy, sedentary lifestyle, and physical activities like standing for longer durations is expected to drive the market growth.

The prevalence of vein diseases is high in population above 60 years at 26%, owing to the factors such as increasing age and development of conditions like hypertension and venous thrombosis. The incidence is lowest in the age group of 0 to 17 at 17% and is majorly due to the risk factors such as genetics, obesity, and lifestyle-related disorders affecting the arteries and veins.

Increasing technological advancements due to continuous R&D activities are anticipated to drive the market for varicose vein treatment devices. Many ongoing clinical trials conducted by the key market players study the use of novel systems over traditional treatment methods to gain a competitive edge over the existing devices. This increases competition in the market enhancing the quality of products introduced in the market. For instance, in June 2019, the Lake Washington Vascular Centre conducted a study based on patients with symptomatic varicose veins treated with Venaseal and Endovenous Thermal Ablation.

The total expenditure of Americans on combined surgical and nonsurgical cosmetic procedures was USD 13.5 billion in 2015. The percentage of nonsurgical procedures has grown by 44% since 2011 and accounted for 42% of the total expenditure done on cosmetic procedures. These statistics highlight that the market for varicose vein treatment devices is attractive for cosmetics purposes.

Further Key Findings from the Report Suggest:

• Based on type, sclerotherapy accounted for the largest market share in 2018

• Medicare offers insurance for sclerotherapy procedures for varicose veins, resulting in its high adoption by the healthcare providers and patients

• Some of the key players operating in the U.S. varicose vein treatment devices market are Medtronic plc; AngioDynamics, Inc.; Biolitec AG; Lumenis Ltd.; Syneron Medical Ltd.; Energist Group; Eufoton srl; Quanta Systems S.p.A.; and Teleflex, Inc.

• In February 2015, Medtronic (then Covidien) received a pre-market approval from the U.S. Food and Drug Administration (FDA) for their new product, VenaSeal closure system-a minimally invasive and uses a medical adhesive to close the damaged vein in patients with vein diseases

 Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Market Segmentation & Scope
                        1.1.1 Type
                        1.1.2 Estimates and forecast timeline
                    1.2 Research Methodology
                    1.3 Information Procurement
                        1.3.1 Purchased database
                        1.3.2 GVR's internal database
                        1.3.3 Secondary sources
                        1.3.4 Primary research
                    1.4 Information or Data Analysis
                        1.4.1 Data analysis models
                    1.5 Market Formulation & Validation
                    1.6 Model Details
                        1.6.1 Commodity flow analysis (Model 1)
                        1.6.2 Volume price analysis (model 2)
                    1.7 List of Secondary Sources
                    1.8 Objectives
                        1.8.1 Objective - 1
                        1.8.2 Objective - 2
Chapter 2 Executive Summary
                    2.1 Market Outlook
                    2.2 Segment Outlook
                        2.2.1 Type
                    2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
                    3.1 Market Segmentation
                    3.2 Penetration & Growth Prospect Mapping
                        3.2.1 Penetration analysis
                    3.3 Market Dynamics
                        3.3.1 Market driver analysis
                            3.3.1.1 Growing preference for minimally invasive treatment procedures
                            3.3.1.2 Introduction of technologically advanced devices
                            3.3.1.3 Increasing geriatric population
                        3.3.2 Market restraint analysis
                            3.3.2.1 High procedural costs and inconsistent reimbursement structure
                            3.3.2.2 Risk factors associated with varicose veins treatment
                        3.3.3 Industry opportunity analysis
                    3.4 U.S. Varicose Vein Treatment Devices Market: Business Environment Analysis Tools
                        3.4.1 PESTLE analysis
                        3.4.2 Porter's five forces analysis
                    3.5 List of Vein Clinics in the U.S.
                    3.6 Vein Diseases: Patient Population in the U.S.
                        3.6.1 Number of patients
                        3.6.2 Female vs. male population
                        3.6.3 Geriatric vs. adult population
                    3.7 U.S. Varicose Vein Treatment Devices Market: Reimbursement Scenario
                    3.8 Varicose Vein Treatment: Recent Trends & Developments
                        3.8.1 VenaSeal closure system
                        3.8.2 Varithena
                    3.9 Varicose Vein Treatment: Ongoing Clinical Trials
Chapter 4 U.S. Varicose Vein Treatment Devices Market: Type Analysis
                    4.1 U.S. Varicose Vein Treatment Devices Type Market Share Analysis, 2018 & 2026
                    4.2 U.S. Varicose Vein Treatment Devices Type Market: Segment Dashboard:
                    4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Type Segment
                        4.3.1 Endovenous Ablation (EVLA)
                            4.3.1.1 Endovenous ablation market, 2015 - 2026 (USD Million)
                            4.3.1.2 Laser Ablation
                                4.3.1.2.1 Laser ablation market, 2015 - 2026 (USD Million)
                            4.3.1.3 Radiofrequency Ablation
                                4.3.1.3.1 Radiofrequency ablation market, 2015 - 2026 (USD Million)
                        4.3.2 Sclerotherapy
                            4.3.2.1 Sclerotherapy market, 2015 - 2026 (USD Million)
                        4.3.3 Surgical Ligation & Stripping
                            4.3.3.1 Surgical ligation & stripping market, 2015 - 2026 (USD Million)
Chapter 5 Competitive Analysis
                    5.1 Recent Developments & Impact Analysis, by Key Market Participants
                    5.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
                    5.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
                    5.4 Company Profiles
                        5.4.1 Medtronic
                            5.4.1.1 Company overview
                            5.4.1.2 Financial performance
                            5.4.1.3 Product benchmarking
                            5.4.1.4 Strategic initiatives
                            5.4.1.5 SWOT analysis
                        5.4.2 AngioDynamics, Inc.
                            5.4.2.1 Company overview
                            5.4.2.2 Financial performance
                            5.4.2.3 Product benchmarking
                            5.4.2.4 Strategic initiatives
                            5.4.2.5 SWOT analysis
                        5.4.3 biolitec AG
                            5.4.3.1 Company overview
                            5.4.3.2 Product benchmarking
                            5.4.3.3 Product benchmarking
                        5.4.4 Syneron Medical Ltd.
                            5.4.4.1 Company overview
                            5.4.4.2 Financial performance
                            5.4.4.3 Product benchmarking
                            5.4.4.4 Strategic initiatives
                            5.4.4.5 SWOT analysis
                        5.4.5 Lumenis
                            5.4.5.1 Company overview
                            5.4.5.2 Financial performance
                            5.4.5.3 Strategic initiatives
                            5.4.5.4 SWOT analysis
                        5.4.6 Energist Ltd.
                            5.4.6.1 Company overview
                            5.4.6.2 Product benchmarking
                            5.4.6.3 Strategic initiatives
                        5.4.7 Eufoton s.r.l.
                            5.4.7.1 Company overview
                            5.4.7.2 Product benchmarking
                        5.4.8 Teleflex Incorporated
                            5.4.8.1 Company overview
                            5.4.8.2 Financial performance
                            5.4.8.3 Product benchmarking
                            5.4.8.4 Strategic initiatives
                            5.4.8.5 SWOT analysis
                        5.4.9 Quanta System
                            5.4.9.1 Company overview
                            5.4.9.2 Product benchmarking
                            5.4.9.3 Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 Sclerotherapy reimbursement codes in the U.S.
TABLE 3 Vein clinics in Mid-Atlantic region (U.S.)
TABLE 4 Vein clinics in Mid-West region (U.S.)
TABLE 5 Vein clinics in North-East region (U.S.)
TABLE 6 Vein clinics in North-West region (U.S.)
TABLE 7 Vein clinics in South-East region (U.S.)
TABLE 8 Vein clinics in South-West region (U.S.)
TABLE 9 Reimbursement codes for endovenous ablation
TABLE 10 Reimbursement codes for sclerotherapy
TABLE 11 Reimbursement codes for stripping and ligation

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. varicose vein treatment devices market outlook, 2018
Fig. 9 Market trends & outlook
Fig. 10 U.S. varicose vein treatment devices market segmentation
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Strong preference for non-invasive procedures (In Million)
Fig. 14 Expected geriatric population in the U.S., 2012 - 2050 (Million)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 U.S. varicose vein treatment devices market - PESTLE analysis
Fig. 17 U.S. varicose vein treatment devices type market: Porter's five forces model
Fig. 18 U.S. varicose vein treatment devices market: Patient population
Fig. 19 Varicose vein treatment devices market: Geriatric vs. adult population
Fig. 20 U.S. varicose vein treatment devices type market share analysis, 2018 & 2026
Fig. 21 U.S. varicose vein treatment devices type market: Segment dashboard
Fig. 22 Endovenous ablation market, 2015 - 2026 (USD Million)
Fig. 23 Laser ablation market, 2015 - 2026 (USD Million)
Fig. 24 Radio frequency ablation market, 2015 - 2026 (USD Million)
Fig. 25 Sclerotherapy market, 2015 - 2026 (USD Million)
Fig. 26 Surgical ligation & stripping market, 2014 - 2026 (USD Million)
Fig. 27 Company/competition categorization (Key innovators, market leaders, emerging players)
Fig. 28 Strategy framework
Fig. 29 U.S. varicose vein treatment devices competitive landscape: Market position analysis (based on products, regional presence, and recent updates (2018))